Efficacy of epidermal growth factor receptor–tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports

Epidermal growth factor receptor (EGFR) mutations are common in lung adenocarcinoma (ADC) but rare in squamous cell carcinoma (SQC). The efficacy of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) for SQC with EGFR mutations is unclear. The aim of this study was to evaluate the efficacy of EGFR-TKIs for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Liu, Yongmei, Zhang, Yan, Zhang, Li, Liu, Bin, Wang, Yongsheng, Zhou, Xiaojuan, Li, Yanying, Zhao, Qian, Gong, Youling, Zhou, Lin, Zhu, Jiang, Ding, Zhenyu, Wang, Jin, Peng, Feng, Huang, Meijuan, Li, Lu, Ren, Li, Lu, You
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564798/
https://ncbi.nlm.nih.gov/pubmed/28591695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17915
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados